Cargando…

Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer

Intraperitoneal chemotherapy has shown promising results for the treatment of peritoneal carcinomatosis in gastric cancer. However, the implantation of an intraperitoneal chemotherapy port may be associated with catheter-related complications. The authors describe a case of cutaneous port-site recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chue, Koy Min, Chan, Dexter Yak Seng, So, Jimmy B.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292231/
https://www.ncbi.nlm.nih.gov/pubmed/32566726
http://dx.doi.org/10.1515/pp-2020-0102
_version_ 1783546067289112576
author Chue, Koy Min
Chan, Dexter Yak Seng
So, Jimmy B.Y.
author_facet Chue, Koy Min
Chan, Dexter Yak Seng
So, Jimmy B.Y.
author_sort Chue, Koy Min
collection PubMed
description Intraperitoneal chemotherapy has shown promising results for the treatment of peritoneal carcinomatosis in gastric cancer. However, the implantation of an intraperitoneal chemotherapy port may be associated with catheter-related complications. The authors describe a case of cutaneous port-site recurrence secondary to tumour seeding from an intraperitoneal chemotherapy access port.
format Online
Article
Text
id pubmed-7292231
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-72922312020-06-18 Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer Chue, Koy Min Chan, Dexter Yak Seng So, Jimmy B.Y. Pleura Peritoneum Clinical Images Intraperitoneal chemotherapy has shown promising results for the treatment of peritoneal carcinomatosis in gastric cancer. However, the implantation of an intraperitoneal chemotherapy port may be associated with catheter-related complications. The authors describe a case of cutaneous port-site recurrence secondary to tumour seeding from an intraperitoneal chemotherapy access port. De Gruyter 2020-05-15 /pmc/articles/PMC7292231/ /pubmed/32566726 http://dx.doi.org/10.1515/pp-2020-0102 Text en © 2020 Chue et al., published by De Gruyter http://creativecommons.org/licenses/by/4.0 This work is licensed under the Creative Commons Attribution 4.0 Public License.
spellingShingle Clinical Images
Chue, Koy Min
Chan, Dexter Yak Seng
So, Jimmy B.Y.
Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer
title Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer
title_full Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer
title_fullStr Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer
title_full_unstemmed Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer
title_short Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer
title_sort cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292231/
https://www.ncbi.nlm.nih.gov/pubmed/32566726
http://dx.doi.org/10.1515/pp-2020-0102
work_keys_str_mv AT chuekoymin cutaneousportsiterecurrencesecondarytotumourseedingfollowingimplantationofanintraperitonealchemotherapyaccessportforgastriccancer
AT chandexteryakseng cutaneousportsiterecurrencesecondarytotumourseedingfollowingimplantationofanintraperitonealchemotherapyaccessportforgastriccancer
AT sojimmyby cutaneousportsiterecurrencesecondarytotumourseedingfollowingimplantationofanintraperitonealchemotherapyaccessportforgastriccancer